ID: ALA1650002

Max Phase: Preclinical

Molecular Formula: C17H16N6O3

Molecular Weight: 352.35

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): DB1679
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CO/N=C(/N)c1ccc(-c2ccc(-c3ccc(/C(N)=N/O)cn3)o2)nc1

    Standard InChI:  InChI=1S/C17H16N6O3/c1-25-23-17(19)11-3-5-13(21-9-11)15-7-6-14(26-15)12-4-2-10(8-20-12)16(18)22-24/h2-9,24H,1H3,(H2,18,22)(H2,19,23)

    Standard InChI Key:  RTNOOAOQALMKNE-UHFFFAOYSA-N

    Associated Targets(Human)

    Liver microsome 8277 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Cytochrome P450 1A2 26471 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Cytochrome P450 3A4 53859 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Cytochrome P450 4F2 83 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Trypanosoma brucei rhodesiense 7991 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Trypanosoma brucei brucei 13300 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Liver microsome 4459 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Cytochrome P450 1A2 75 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Cytochrome P450 4F1 2 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 352.35Molecular Weight (Monoisotopic): 352.1284AlogP: 1.76#Rotatable Bonds: 5
    Polar Surface Area: 145.14Molecular Species: NEUTRALHBA: 7HBD: 3
    #RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 11.30CX Basic pKa: 5.01CX LogP: 0.80CX LogD: 0.80
    Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.27Np Likeness Score: -0.69

    References

    1. Wenzler T, Boykin DW, Ismail MA, Hall JE, Tidwell RR, Brun R..  (2009)  New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.,  53  (10): [PMID:19620327] [10.1128/aac.00225-09]
    2. Generaux CN, Ainslie GR, Bridges AS, Ismail MA, Boykin DW, Tidwell RR, Thakker DR, Paine MF..  (2013)  Compartmental and enzyme kinetic modeling to elucidate the biotransformation pathway of a centrally acting antitrypanosomal prodrug.,  41  (2): [PMID:23223498] [10.1124/dmd.112.048231]

    Source